Log In
Print
BCIQ
Print
Print this Print this
 

MVA85A-IMX313

  Manage Alerts
Collapse Summary General Information
Company Imaxio S.A.
DescriptionViral vector vaccine encoding antigen 85A fused to Imaxio's IMX313 antigen re-engineering technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationTuberculosis
Indication DetailsPrevent tuberculosis (TB) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today